Bulgaria: A Rising Hub for Clinical Research in Europe Bulgaria may not be the first country that comes to mind when considering a hub for cutting-edge clinical research. However, this Balkan nation has been steadily gaining recognition as a key player in the industry. With a thriving clinical trials sector valued at approximately $330 million, Bulgaria ranks among the top 20 countries globally in Read more
Key Takeaways from SCOPE 2025 | Cromos Pharma
Key Takeaways from SCOPE 2025: Insights from Cromos Pharma’s US Business Development Director With the conclusion of the 16th Annual Summit for Clinical Operations Executives (SCOPE) held from February 3-6, 2025, in Orlando, industry experts shared key insights into the future of clinical research and development. This year’s discussions centered on artificial intelligence, decentralized clinical trials (DCTs), localization, and strategies for improving efficiency and diversity in clinical trials. Read more
Clinical Research Focus. 37th Edition Reflections from JPM 2025: A CEO’s Perspective on Biopharma’s New Era        Having just returned from the 2025 JP Morgan Healthcare Conference, I am energized by the transformative developments shaping the biopharma industry. With over 8,000 professionals in attendance and more than 500 companies presenting, the conference underscored the resilience, creativity, and forward-thinking Read more
The Future of Cancer Treatment | World Cancer Day | Cromos Pharma
World Cancer Day 2025: How Clinical Trials Are Shaping the Future of Cancer Treatment On this World Cancer Day, we reflect on the progress made in the fight against cancer and the challenges ahead. With over 2 million new cases diagnosed in the US in 2024 alone, cancer remains a leading cause of death. However, breakthroughs in early detection, targeted therapies, and clinical trial innovations are reshaping oncology care. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us